Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria

NCT00561171 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Type II Diabetes Mellitus

Interventions

DRUG: SPP635

Sponsor

Speedel Pharma Ltd.